A Comparative Evaluation of Intranasal Midazolam, Ketamine and their Combination for Sedation of Young Uncooperative Pediatric Dental Patients: A Triple Blind Randomized Crossover Trial

The purpose of this study was to evaluate and compare the efficacy and safety of intranasal (IN) administration of midazolam (M), ketamine (K) and their combination (MK) to produce moderate sedation in young, uncooperative pediatric dental patients. Study design: In this three stage crossover trial forty five uncooperative ASA type-1 children, who required dental treatment, were randomly assigned to receive one of the three drugs/combination by IN route during three subsequent visits. The efficacy and safety of the agents were assessed by overall success rate and by monitoring of vital signs, respectively. Results: The onset of sedation was rapid with K as compared to M and MK. The difference was statistically significant (P<0.01) between K and M. The overall success rate was 89% with K, MK was 84% and 69% with M. The difference between the overall success rates of K and M was statistically significant (P<0.01). Vital signs were within physiological limits and there were no significant adverse effects with any medication. Conclusions: M, K and MK are safe and effective by IN route to produce moderate sedation for providing dental care to pediatric dental patients who have been otherwise indicated for treatment under general anesthesia.

Intranasal route, moderate sedation, analgesia, midazolam and ketamine

1. Al-Rakaf H, Bello LL, Turkustani A, Adenubi JO. Intra-nasal midazolam in conscious sedation of young paediatric dental patients. Int J Paediatr Dent, 11(1): 33–40. 2001.

2. Fields H, Machen J, Murphy M. Acceptability of various behavior management techniques relative to types of dental treatment. Pediatr Dent, 6: 199–203, 1984.

3. Lawrence S, McTigue DJ, Wilson S, Odom JG, Waggoner WF, Fields HW. Parental attitudes toward behavior management techniques used in pediatric dentistry. Pediatr Dent, 13: 151–155, 1991.

4. Malamed SF. Sedation. A guide to patient management. 3rd ed. Mosby, Boston, USA. 1995.

5. Roelofse JA, Van der Biji P. Comparison of rectal midazolam and diazepam for premedication in pediatric dental patients. J Oral Maxillofac Surg, 51 (5): 525–9, 1993.

6. Flaiz CM and Nowak AJ. Evaluation of the sedative effect of rectally administered diazepam for the young dental patients. Pediatr Dent, 7(4): 292–6, 1985.

7. Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Clin Pharmacokinet, 42: 1107–1128, 2002.

8. Hussain AA. Mechanism of nasal absorption of drugs. Prog Clin Biol Res, 292: 261–272, 1989.

9. Singh N, Pandey RK, Saksena AK, Jaiswal JN. A comparative evaluation of oral midazolam with other sedative as premedication in pediatric dentistry. J Clin Pediatr Dent, 26 (2): 161–164, 2002.

10. Koirala B, Pandey RK, Saksena AK, Kumar R, Sharma S. A comparatieve evaluation of newer sedatives in conscious sedation. J Clin Pediatr Dent, 30: 273–276, 2006.

11. Rey E, Delaunay L, Pons G, Murat I, Richard MO, Saint Maurice C, Olive G. Pharmacokinetics of midazolam in children; comparative study of intranasal and intravenous administration. Eu J Clin Pharma, 41: 355–357, 1991.

12. Walberg EJ, Wills RJ, Eckhert J. Plasma concentration of midazolam in children following intranasal administration. Anesthesiology, 74: 233–235, 1991.

13. Lee-Kim SJ, Fadavi S, Punwani I, Koerber A. Nasal Versus oral midazolam sedation for pediatric dental patients. J Dent Child (chic), 71(2): 135–138, 2004.

14. Alfonzo-Echeverri EC, Berg JH, Wild TW, Glass NC. Oral ketamine for pediatric outpatient dental surgery sedation. Pediatr Dent, 15: 182–185, 1993.

15. Gutstein HB, Johnson KL, Heard MB, Gregory GA. Oral ketamine preanesthetic medication in children. Anesthesiology, 76: 28–33, 1992.

16. Rosenberg M. Oral ketamine for deep sedation of difficult to manage children who are mentally handicapped: case report. Pediatr Dent, 13: 221–223, 1991.

17. Debnath S and Pande Y. A comparative study of oral premedication in children with ketamine and midazolam. Indian J Anaesth, 47(1): 45–47, 2003.

18. Bui T, Redden RJ, Murphy S. A comparasion study between Ketamine and Ketamine-promethazine combination for oral sedation in pediatric dental patients. Anaesth Prog, 49(1): 14–18, 2002.

19. Damle SG, Gandhi M, Laheri V. Comparision of oral ketamine and and oral midazolam as a sedative agents in pediatric dentistry. J Indian Soc Padod Prev Dent, 26(3): 97–101, 2008.

20. Grant LS, Nimmo WS, Clement JA. Pharmacokinetics and analgesic effects of IM and oral ketamine. Br J Anesth, 53: 805–809, 1981.

21. Funk W, Jacob W, Riedl T, Taeger K. Oral preanesthetic medication for children: double-blind randomized study of a combination of midazolam and ketamine vs midazolam or ketamine alone. Brit J Anesth, 84(3): 335–340, 2000.

22. Acworth JP, Purdie D, Clark RC. Intravenous ketamine plus midazolam is superior to intranasal midazolam for emergency pediatric procedural sedation. Emerg Med J, 18 (1): 39–45, 2001.

23. Gharde P, Chauhan S, Kiran U. Evaluation of Efficacy of intranasal Midazolam, Ketamine and their Mixture as premedication and its relation with bispectral index in children with tetralogy of fallot undergoing intracardiac repair. Ann Card Anaesth, 9: 25–30, 2006.

24. Roelofse JA, Shipton EA, De La Harpe CJ, Blignaut RJ. Intranasal sufentanil/Midazolam Versus Ketamine/Midazolam for analgesia/sedation in the pediatric population prior to undergoing multiple dental extractions under general anesthesia: A prospective, double-blind, randomized comparison. Anesth Prog, 51: 114–121, 2004.

25. Padmanabhan MN, Pande RK, Saksena AK, Chandra G. A comparative evaluation of agents producing Analgo-sedation in pediatric dental patients. J Clin Pediat Denti, 34(2): 183–189, 2009.

26. American Academy of Pediatrics; American Academy of Pediatric Dentistry, Coté CJ. Wilson S. Work Group on Sedation. Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: an update. Paediatr, Jan 118(6): 2587–602, 2006.

27. Citerio G, Franzosi MG, Latini R. Anaesthesiological strategies in elective craniotomy: randomized, equivalence, open trial–the NeuroMorfeo trial. Trials, Apr10: 19, 2009.

28. Mazaheri R, Eshghi A, Bashardoost N, Kavyani N. Assessment of intranasal midazolam administration with a dose of 0.5 mg/Kg in behavior management of uncooperative children. J Clin Pediatr Dent, 32(2): 95–99, 2007.

29. Gilchrist F, Cairns AM, Leitch JA. The use of intranasal midazolam in the treatment of paediatric dental patients. Anaesthesia, 62(12): 1262–5, 2007.

30. Lloyd C.J, Alredy T, Lowry JC. Intranasl midazolam as an alternative to general anesthesia in the management of children with oral and maxillofacial trauma. Br J Oral Maxillofac Surg, 38(6): 593–595, 2000.

31. Kain ZN, Mayes LC. Anxiety in children during the peri-operative period. In Bamstein M, Gennevro J (eds): Child Development and Behavioral Pediatrics. Mahwah NJ, Lawrence Erlbaum Associates, 1996; 85–103.

32. Wilton NC, Leigh J, Rosen DR, Pandit UA. Preanesthetic sedation of preschool children using intranasal midazolam, Anesthesiology, 69: 972–975, 1988.

33. Saint –Maurice C, Landias A, Delleur MM, Esteve C, MacGee K, Murat I. The use of midazolam in diagnostic and short surgical procedures in children. Acta Anesthesiol Scand Supplñ, 92: 39, 1990.

34. Audenaert SM, Wagner Y, Montgomery CL, Lock RL, Colclough R, Kuhn RJ, Johnson GL, Pedigo NW. Cardio-respiratory effects of premedication for children. Anesth Analg, 80: 506–510, 1995.

35. Sarkar MA. Drug metabolism in the nasal mucosa. Pharmaceutic Res, 9: 1–3, 1992.

36. Lowhagen P, Johanson BB, Nordberg C. The nasal route of cerebrospinal fluid drainage in man. A light microscope study. Neuropathol Appl Neurobiol, 20(6): 543–550, 1994.

37. Jackson RT, Tiggs J, Arnold W. Subarachnoid space of the CNS, nasal mucosa and lymphatic system. Arch Otolaryngol; 105(4): 180–184, 1979.

38. Committee on drugs, Alternative routes of drug administration— advantages and disadvantages (subject review). American Academy of Pediatrics. Pediatrics, 100(1): 143–152, 1997.

39. Fukata O, Braham RL, Yanase H, Kurosu K. The sedative effect of intranasal midazolam administration in the dental treatment of patients with mental disabilities. Part 2: optimal concentration of intranasal midazolam. J Clin Pediatr Dent, 18(4): 259–65, 1994.

40. Fuks A, Kaufman E, Ram D, Hovav S, Shapira J. Assessment of two doses of intranasal midazolam for sedation of young pediatric dental patient. Pediatr Dent, 16: 301, 1994.

41. Theroux MC, West DW, Corddry DH, Hyde PM, Bachrach SJ, Cronan KM, Kettrick RG. Efficacy of intranasal midazolam in facilitating suturing of lacerations in preschool children in the emergency department. Pediatrics, 91(3): 624–7, 1993.

42. Karl HW, Rosenberger JL, Larach MG, Ruffle JM. Transmucosal administration of midazolam for premedication of pediatric patients. Comparison of the nasal and sublingual routes. Anesthesiology, 78(5): 885–91, 1993.

43. Hannallah RS and Patel RI. Low dose intramuscular ketamine for anesthesia preinduction in young children undergoing brief outpatient procedures. Anesthesiology, 70: 598–600, 1989.

44. Hollister GR and Burn JNB. Side effects of ketamine in pediatric anesthesia. Anesth Analg, 53: 264–7, 1974.